documents: FDA-2015-M-2634-0001

Regulatory documents from Regulations.gov including rules, proposed rules, notices, and supporting materials.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id agency_id docket_id title document_type subtype posted_date posted_year posted_month comment_start_date comment_end_date last_modified fr_doc_num open_for_comment withdrawn object_id
FDA-2015-M-2634-0001 FDA FDA-2015-M-2634 Premarket Approval Response from FDA CDRH to Calderma Laboratories, L.P., Restylane Lyft with Lidocaine Other Approval 2015-09-16T04:00:00Z 2015 9 2015-09-16T04:00:00Z   2015-09-16T16:48:23Z   0 0 0900006481c7990f

Links from other tables